Cargando…
Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity
Anthracyclines, such as doxorubicin, are effective chemotherapeutic agents for the treatment of cancer, but their clinical use is associated with severe and potentially life-threatening cardiotoxicity. Despite decades of research, treatment options remain limited. The mitochondria is commonly consid...
Autores principales: | Wu, Bin Bin, Leung, Kam Tong, Poon, Ellen Ngar-Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837080/ https://www.ncbi.nlm.nih.gov/pubmed/35163838 http://dx.doi.org/10.3390/ijms23031912 |
Ejemplares similares
-
Recent Advances in Mitochondrial Fission/Fusion-Targeted Therapy in Doxorubicin-Induced Cardiotoxicity
por: Maneechote, Chayodom, et al.
Publicado: (2023) -
The true colors of autophagy in doxorubicin-induced cardiotoxicity
por: Xiao, Bin, et al.
Publicado: (2019) -
Targeting mitochondrial dynamics proteins for the treatment of doxorubicin-induced cardiotoxicity
por: Chen, Rui, et al.
Publicado: (2023) -
Mechanisms and Drug Intervention for Doxorubicin-Induced Cardiotoxicity Based on Mitochondrial Bioenergetics
por: Ling, Guanjing, et al.
Publicado: (2022) -
Effects of doxorubicin‐induced cardiotoxicity on cardiac mitochondrial dynamics and mitochondrial function: Insights for future interventions
por: Osataphan, Nichanan, et al.
Publicado: (2020)